NCT05820464 is a clinical trial of DDA Doppler in Hypoxia, sponsored by Orthogyn Medical Center, Bulgaria.

Who is sponsoring NCT05820464?

NCT05820464 is sponsored by Orthogyn Medical Center, Bulgaria.

What drugs are being tested in NCT05820464?

Interventions in NCT05820464: DDA Doppler.

What condition does NCT05820464 study?

NCT05820464 studies Hypoxia, Anemia.

Is NCT05820464 still recruiting?

NCT05820464 is currently status unknown. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT05820464

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diastolic Deceleration Area in Early-onset FGR

Status unknown Last updated 3 May 2023

What this trial tests

trial testing DDA Doppler in Hypoxia in 300 participants. Status unknown.

Timeline

19 April 2022

Primary endpoint
1 February 2024

1 April 2024

Quick facts

Lead sponsor	Orthogyn Medical Center, Bulgaria
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	19 April 2022
Primary completion	1 February 2024
Estimated completion	1 April 2024
Sites	1 location across Bulgaria

Drugs / interventions tested

DDA Doppler

Conditions studied

Hypoxia — all drugs for Hypoxia →
Anemia — all drugs for Anemia →

Sponsor

Orthogyn Medical Center, Bulgaria

Who can join

Adults 18 to 48, female only, with Hypoxia or Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

DDA is a new Doppler parameter aiming to assess fetal well-being in-utero. Early-onset SGR is a specific subgroup of fetuses where the clinical application of this Doppler modality could play an important role in the detection of hypoxia, anemia, and brain-sparing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of DDA Doppler

Trials testing the same drug.

NCT05837195 — Diastolic Deceleration Area in Late-onset FGR · unknown

Other recruiting trials for Hypoxia

Currently open trials in the same condition.

NCT07479511 — Adaptation of Lung Transplant Recipients at Extreme Altitude · active not recruiting
NCT07287293 — Endotracheal Tube Suctioning Versus No Suctioning During Emergence From General Anesthesia · NA · recruiting
NCT07389083 — The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic Broncho · NA · recruiting
NCT07307560 — High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients · NA · recruiting
NCT07408388 — Pulse Oximeter Accuracy During Stable Hypoxia Plateaus · active not recruiting

Other Orthogyn Medical Center, Bulgaria trials

Trials by the same sponsor.

NCT05837195 — Diastolic Deceleration Area in Late-onset FGR · unknown
NCT04456660 — Comprehensive Assessment of Risks for Miscarriage. · unknown
NCT04447248 — qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05820464 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthogyn Medical Center, Bulgaria
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05820464.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing